ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group Meetings for July

June 27, 1975

Karmanos Cancer Institute, CDC, Blue Cross To Begin Environmental Cancer Program

June 4, 2010

In Brief: Fauci, Washington Univ. Chancellor, Merck Chairman Reportedly On Final NIH Director List

August 25, 1989

DRCCA Board, ACCI Agree On New Core Grant Guidelines

February 6, 1981

Roswell Park, Karmanos Read The Cancer Letter Interactive.

December 1, 2000

When Is A Cancer Cured? NCI Suggest One-Year Survival Rates Useful In Determining Advances

August 1, 1975